Inventor · disambiguated record
Scott J. Dylla
Also filed as: DYLLA SCOTT · DYLLA SCOTT J
51 granted patents·21 pending applications·432 citations·filing 2005–2025
99Inventor score
Top patents by PatentIndex Score
72 records- 0198US11033634B2Light chain variable regionsABBVIE STEMCENTRX LLC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0297US9089615B2Anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·21 cites·30 claims
- 0397US8986972B2Nucleic acid encoding DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Mar 24, 2015·22 cites·30 claims
- 0496US9937268B2Anti-DLL3 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 10, 2018·9 cites·30 claims
- 0596US9931421B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0696US9931420B2Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0796US9878053B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 30, 2018·9 cites·30 claims
- 0896US9867887B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 16, 2018·9 cites·30 claims
- 0996US9861708B2Kits containing DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 9, 2018·9 cites·30 claims
- 1096US9855343B2Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 2, 2018·9 cites·30 claims
- 1196US9775916B1Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2017·Granted Oct 3, 2017·9 cites·30 claims
- 1296US9770518B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 26, 2017·9 cites·30 claims
- 1396US9764042B1Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 19, 2017·9 cites·30 claims
- 1496US9358304B1Methods of making DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Jun 7, 2016·10 cites·30 claims
- 1596US9352051B1Kits containing DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 31, 2016·10 cites·30 claims
- 1696US9353182B2Anti-DLL3 antibodiesSTEMCENTRX INC·Filed 2015·Granted May 31, 2016·10 cites·21 claims
- 1796US9334318B1Multivalent DLL3 antibodiesSTEMCENTRX INC·Filed 2016·Granted May 10, 2016·11 cites·28 claims
- 1896US9155803B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Oct 13, 2015·10 cites·30 claims
- 1996US9133271B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Sep 15, 2015·10 cites·30 claims
- 2096US9089617B2Anti-DLL3 antibody drug conjugatesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·13 cites·30 claims
- 2195US11648277B2Combination therapy with gold controlled transgenesCHIMERA BIOENGINEERING INC·Filed 2022·Granted May 16, 2023·2 cites·20 claims
- 2295US10137204B2Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2016·Granted Nov 27, 2018·8 cites·33 claims
- 2395US9486537B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 8, 2016·9 cites·22 claims
- 2495US9480757B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·9 cites·29 claims
- 2595US9107961B2Anti-DLL3 antibody drug conjugates for treating cancerSTEM CENTRX INC·Filed 2014·Granted Aug 18, 2015·11 cites·30 claims
- 2695US9089616B2Anti-DLL3 antibody drug conjugates and methods of useSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 2794US9090683B2Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 2893US9409995B2PTK7 modulators and methods of useFOORD ORIT·Filed 2012·Granted Aug 9, 2016·39 cites·29 claims
- 2993US7641897B2Feeder layer and serum independent embryonic stem cellsUNIV LELAND STANFORD JUNIOR·Filed 2005·Granted Jan 5, 2010·19 cites·3 claims
- 3090US9777070B2Anti-PTK7 antibody-drug conjugatesPFIZER·Filed 2015·Granted Oct 3, 2017·14 cites·60 claims
- 3190US9534058B2Anti-CD324 monoclonal antibodies and uses thereofSTEM CENTRX INC·Filed 2013·Granted Jan 3, 2017·10 cites·10 claims
- 3290US9345784B1Methods of delivering DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 24, 2016·3 cites·30 claims
- 3389US10836831B2Anti-PTK7 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2018·Granted Nov 17, 2020·3 cites·23 claims
- 3489US9676850B2Anti SEZ6 antibodies and methods of useSTEM CENTRX INC·Filed 2013·Granted Jun 13, 2017·10 cites·12 claims
- 3589US9173959B1Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2015·Granted Nov 3, 2015·3 cites·30 claims
- 3688US9481727B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·2 cites·26 claims
- 3788US7723112B2Compositions and methods for treating and diagnosing cancerUNIV MICHIGAN·Filed 2006·Granted May 25, 2010·27 cites·18 claims
- 3886US8420885B2Determining the capability of a test compound to affect solid tumor stem cellsCLARKE MICHAEL F·Filed 2011·Granted Apr 16, 2013·5 cites·33 claims
- 3983US9320812B2Modulators and methods of useHAMPL JOHANNES·Filed 2011·Granted Apr 26, 2016·8 cites·36 claims
- 4082US9914784B2PTK7 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2016·Granted Mar 13, 2018·3 cites·19 claims
- 4178US9458231B2Modulators and methods of useDYLLA SCOTT J·Filed 2011·Granted Oct 4, 2016·7 cites·9 claims
- 4277US10533051B2Anti SEZ6 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 14, 2020·1 cites·17 claims
- 4377US8044259B2Determining the capability of a test compound to affect solid tumor stem cellsUNIV MICHIGAN·Filed 2007·Granted Oct 25, 2011·4 cites·32 claims
- 4477US2019247510A1Dll3 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2019·Application pending·0 cites
- 4575US10017565B2Modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2016·Granted Jul 10, 2018·2 cites·19 claims
- 4675US2019046656A1Dll3 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2018·Application pending·0 cites
- 4771US2025206805A1Combination Therapy with Gold Controlled TransgenesCHIMERA BIOENGINEERING INC·Filed 2025·Application pending·0 cites
- 4870US9381205B2Anti-EFNA4 antibody-drug conjugatesPFIZER·Filed 2014·Granted Jul 5, 2016·0 cites·27 claims
- 4967US2020181256A1Anti sez6 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2019·Application pending·0 cites
- 5065US2021046117A1Combination Therapy with Gold Controlled TransgenesCHIMERA BIOENGINEERING INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →